HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cells.
about
Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virusThe roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunctionThe HIV matrix protein p17 subverts nuclear receptors expression and induces a STAT1-dependent proinflammatory phenotype in monocytesMyocarditis in CD8-depleted SIV-infected rhesus macaques after short-term dual therapy with nucleoside and nucleotide reverse transcriptase inhibitorsThe consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms.HIV gp120 induces endothelial dysfunction in tumour necrosis factor-alpha-activated porcine and human endothelial cellsT-cell activation, both pre- and post-HAART levels, correlates with carotid artery stiffness over 6.5 years among HIV-infected women in the WIHSHIV Tat induces expression of ICAM-1 in HUVECs: implications for miR-221/-222 in HIV-associated cardiomyopathy.A prospective study of endothelial activation biomarkers, including plasma angiopoietin-1 and angiopoietin-2, in Kenyan women initiating antiretroviral therapyCardiovascular implications from untreated human immunodeficiency virus infection.The contribution of HIV infection to intracranial arterial remodeling: a pilot study.Expanding role of circulating adhesion molecules in assessing prognosis and treatment response in human immunodeficiency virus infectionHuman immunodeficiency virus-1 transgene expression increases pulmonary vascular resistance and exacerbates hypoxia-induced pulmonary hypertension development.State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summaryInflammation, immune activation, and cardiovascular disease in HIV.Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration.Brain large artery inflammation associated with HIV and large artery remodeling.HIV infection and atherosclerosis: evaluating the drivers of inflammation.HIV-specific immune dysregulation and atherosclerosis.HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults.Risk of coronary heart disease in patients with HIV infection.Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis.HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress.Fusion of HIV-1 envelope-expressing cells to human glomerular endothelial cells through an CXCR4-mediated mechanism.Induction of intercellular adhesion molecule-1 on human brain endothelial cells by HIV-1 gp120: role of CD4 and chemokine coreceptors.CD4 and chemokine receptors on human brain microvascular endothelial cells, implications for human immunodeficiency virus type 1 pathogenesis.Basic fibroblast growth factor coating and endothelial cell seeding of a decellularized heparin-coated vascular graft.Blood-brain barrier abnormalities caused by HIV-1 gp120: mechanistic and therapeutic implications.
P2860
Q26851535-7479D6CE-7AC1-401F-94E3-DB81DD3254D0Q28386344-35C15D6B-3BD2-4848-8DA0-E5F14B417CA2Q28730200-181711F8-B472-454D-8A85-2F93F9B7197CQ28743987-5AFE27A9-E512-4123-B06C-0A53D5948FE0Q33889580-1DC7D998-E500-4656-B67B-98FF2AC7BD1BQ33954940-726E182E-22E5-451F-AF02-D6051C6A8D6BQ34342183-BB949C12-AB19-40BD-87CA-3529B0BFAC8CQ34653444-F5BECF3E-607E-4FCB-AB3D-6F454DA690DAQ34756452-FCC7DF0E-DE77-4AD7-8EB1-12219AA25E5BQ34793193-DD38ECFB-A0BB-4282-B22D-614E6C5DC038Q35297689-03679AFD-F949-4D2D-85C0-E5A805345F1FQ35946434-8C3CEA95-9555-441A-AD7E-71F4A0B2FFB7Q36810837-1810BC58-C7E9-4EE2-859F-CE83623DC698Q36812073-C86F428E-71D2-46C6-90B9-5CBDC5104EACQ36957752-06DEF945-83DE-4453-88ED-05A6E73CEDF8Q36980757-BB32A4D0-4EF7-458B-9F8C-C69F02723005Q37547729-942B4E87-E6FA-4215-96BF-F6F104C79B18Q38007417-B61C8E6C-218E-45B2-BEDF-96DA4A687F0BQ38013681-F11E91EB-C2D2-4054-A2FE-4E636623DE67Q38021848-F91D7DB9-6D37-4151-B15A-64CD00142731Q38261508-6A6F51CB-09B3-49F0-A763-00BA87D57CF3Q39439341-C2C5017F-CEC3-4EDE-AADB-E51991CB3293Q40089833-EAEB7B1F-604C-47AB-90B4-527672ACC7CFQ42811872-EB13D7A1-CE56-4386-8596-A489BA948E64Q44703373-9F5E1119-7CE3-4DC0-A6E1-EC07D6D5ED30Q45497122-5F2D4B06-DCDD-43C8-B717-05E24869F6FAQ47312980-A4B892E3-EB4D-4F6B-A29F-0D80D98DAFEEQ52623530-2049B009-6485-4CF4-9DA8-B74EE75B6754
P2860
HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cells.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
HIV-1 envelope glycoprotein 12 ...... on by human endothelial cells.
@en
type
label
HIV-1 envelope glycoprotein 12 ...... on by human endothelial cells.
@en
prefLabel
HIV-1 envelope glycoprotein 12 ...... on by human endothelial cells.
@en
P2093
P2860
P1476
HIV-1 envelope glycoprotein 12 ...... on by human endothelial cells.
@en
P2093
Changyi Chen
Zeguang Ren
P2860
P2888
P304
P356
10.1038/LABINVEST.3780418
P577
2002-03-01T00:00:00Z